Skip to main content
Premium Trial:

Request an Annual Quote

It is Finished: International Human Genome Consortium Announces Completion of Human Genome Project

NEW YORK, April 15 - The International Human Genome Consortium announced today that the Human Genome Project, in which the 3 billion base pairs of the human genome were sequenced by a team of researchers spread across the globe, is complete.

 

The project has been completed nearly two years ahead of schedule, the organization said.

 

The major participants in this project included the National Human Genome Research Institute, the Wellcome Trust Sanger Institute, as well as sequencing centers at MIT's Whitehead Institute, Washington University in St. Louis, and Baylor College of Medicine.

 

"We have reached the limits we set on this project, achieving tremendously high standards of quality much more quickly than we hoped, said Jane Rogers, head of sequencing at the Wellcome Trust Sanger Institute.

 

Rogers likened the move from the first draft, completed in June 2000, to the finished product to "moving on from a first-attempt demo music tape to a classic CD."

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.